MB
Merlin Biotech, Inc.
SEC filingBiotechnology · Doylestown, PA
Amount raised$50Ksold at filing
Total offering$50K
Investors in the raise2count reported to the SEC
FiledAug 11, 2026first sale Jun 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Randall HyerExecutive Officer, Director
Jay BhatiaDirector
Nikhil HebleExecutive Officer
Nick SpringExecutive Officer
Carol BrosgartDirector
Loren DanzisDirector
Executive officers, directors and promoters as listed on the Form D.